SELLAS Life Sciences (SLS) Shares Issued (2010 - 2011)
SELLAS Life Sciences (SLS) posted quarterly Shares Issued of $10000.0 for Q4 2017, down 81.82% year-over-year from $55000.0 in Q4 2016, and down 81.82% quarter-over-quarter from $55000.0 in Q4 2016.
Analysis
SELLAS Life Sciences (SLS) Shares Issued (2010 - 2011) Analysis & Trends
SELLAS Life Sciences (SLS) has reported Shares Issued for 6 consecutive years, with $10000.0 the latest figure, recorded in Q4 2017.
- In Q4 2017, Shares Issued fell 81.82% year-over-year to $10000.0; the TTM figure through Dec 2017 stood at $10000.0 (down 81.82% YoY), while the FY2017 annual figure was $10000.0, down 81.82% from the prior year.
- Shares Issued fell to $10000.0 in Q4 2017 per SLS's latest filing, from $55000.0 in the prior quarter.
- Across five years, Shares Issued topped out at $5.6 million in Q1 2013 and bottomed at $10000.0 in Q4 2017.
- Historically, Shares Issued has averaged $1.9 million across 3 years, with a median of $55000.0 in 2016.
- On a YoY basis, Shares Issued climbed as much as 81.82% in 2017 and fell as far as 81.82% in 2017.
- SELLAS Life Sciences' Shares Issued stood at $5.6 million in 2013, then slumped by 99.01% to $55000.0 in 2016, then slumped by 81.82% to $10000.0 in 2017.
- Business Quant data shows SLS's Shares Issued at $10000.0 in Q4 2017, $55000.0 in Q4 2016, and $5.6 million in Q1 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | - |
| 10 | SELLAS Life Sciences | 2.62 Bn | 2.62 Bn | - | - |